Discover trends, market shifts, and competitive outlooks for the heart transplant industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Heart Transplant Market Expected to Grow Between 2025 And 2029?

The size of the heart transplant market has increased rapidly over the past few years. The market, which was valued at $11.49 billion in 2024, is expected to reach $12.66 billion by 2025, growing at an annual compound rate (CAGR) of 10.2%. The strong growth in the historic period is due to significant improvements in medical technology, greater awareness and education, progress in organ preservation, and advancements in healthcare infrastructure.

Projected to experience substantial growth in the coming years, the heart transplant market is set to reach a worth of $18.1 billion in 2029, a development marked by a compound annual growth rate of 9.3%. Factors contributing to this expected growth within the stipulated period include governmental backing and funding, worldwide expansion of transplant programs, augmentation of transplant center capabilities, and the integration of telemedicine and remote monitoring. Main trends expected within the forecast period encompass technological advancements, artificial heart and assist devices, as well as the use of artificial intelligence in donor organ selection.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Which Factors and External Forces Are Driving Demand in the Heart Transplant Market?

The rise in cardiovascular disease occurrences is projected to stimulate further expansion of the heart transplant market. Cardiovascular conditions, which mainly concern the heart and blood arteries, often necessitate a heart transplant at their extreme stages. This medical procedure, often a last resort for those with end-stage heart failure non-responsive to other treatments, enhances the quality of life and life expectancy. The British Heart Foundation, a respected cardiovascular research charity based in the UK, reported for September 2024 that about 7.6 million individuals, comprising 4 million men and 3.6 million women, are currently plagued with heart and circulatory diseases in the UK. They project this number to increase by one million by 2030 and by another two million by 2040, emphasizing the deepening grip of cardiovascular diseases. This cardiovascular disease prevalence thus primes the heart transplant market for growth. Emerging awareness concerning organ donation and transplantation is likely to further spur the heart transplant market’s expansion. This awareness encapsulates the level to which individuals and communities comprehend the processes, significance, and repercussions of organ donation and transplantation in healthcare. By increasing the understanding of organ donation and transplantation, the supply of donors can be expanded, wait-times for recipients reduced, and patient outcomes can be improved. The United Network for Organ Sharing, a US-based non-profit scientific and educational organization, reported in January 2023 a new annual record of 42,887 organ transplants performed in the US during 2022, marking a 3.7% increase from 2021. Notably, this includes having 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants performed, reflecting the heightened awareness about organ donation. Consequently, this burgeoning awareness about organ donation and transplantation stands to power the heart transplant market.

Which Segments in the Heart Transplant Offer the Most Growth?

The heart transplant market covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

What Are the Fastest-Growing Geographies in the Heart Transplant Market?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theHeart Transplant Market’s Growth?

Leading businesses present in the heart transplant market are more and more focusing on the development of novel solutions, like heart preservation technology, to enhance patient health outcomes and transplantation success rates. This technology significantly increases the time a heart can be preserved outside the body in comparison to the traditional ice storage method. Consequently, it allows for better patient health results and fewer post-surgery complications. For example, in May 2023, the U.S. Food and Drug Administration (FDA) gave Xvivo Perfusion AB, a medical technology enterprise based in Sweden, the approval for its Investigational Device Exemption (IDE) application regarding its heart preservation technology, enabling the company to kickstart the “PRESERVE Clinical Trial.” This is a prospective, open-label study conducted in multiple centers and single-handedly focuses on heart transplants performed post non-ischemic heart preservation from extended donors, especially including Donation after Circulatory Death (DCD) hearts. XVIVO’s heart preservation technology’s standout feature is its non-ischemic hypothermic perfusion system that employs cold, oxygenated perfusion to maintain donor hearts while being transported.

View the full report here:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What Are the Key Elements That Define the Heart Transplant Market?

A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model